NuSirt Sciences, Inc. is a biotechnology company based in Nashville, Tennessee, that focuses on developing innovative products for metabolic diseases linked to over-nutrition, such as obesity and diabetes. Established in 2007, the company has created a technology platform that combines natural compounds with pharmaceutical agents to activate sirtuin pathways, aiming to prevent and treat chronic conditions associated with aging. Its flagship product, NS-0100, combines the natural compound leucine with a low dose of metformin to address type 2 diabetes, particularly for patients who experience gastrointestinal side effects from standard metformin treatment. NuSirt is currently conducting Phase 2 clinical trials to determine the optimal dosage of NS-0100. The company has filed eleven patent applications related to its technologies, with two patents already issued, and has successfully completed four clinical studies alongside various pre-clinical investigations.
Evermind, Inc. is a company based in Nashville, Tennessee, founded in 2012, that specializes in monitoring home appliances to enhance the safety and well-being of individuals living alone. Its primary product, also named Evermind, sends text messages or email notifications to users when appliances are activated or deactivated. This system enables caregivers and family members to receive updates on daily activities without intruding on the individual's privacy. By tracking the usage of various electrical devices such as coffee makers, lamps, and garage door openers, Evermind provides a modern solution reminiscent of traditional community watch practices, allowing individuals to maintain their independence while ensuring that their well-being is monitored effectively.
Advanced Catheter Therapies
Series B in 2014
Advanced Catheter Therapies, Inc. is an early-stage medical device company based in Chattanooga, Tennessee, focused on the research and development of innovative catheter technologies aimed at treating vascular diseases. Founded in 2008, the company specializes in addressing conditions such as thrombosis, inflammation, occlusions, and restenosis. Among its offerings is the Occlusion Perfusion Catheter, a multi-lumen balloon catheter designed to temporarily block blood flow in specific regions, allowing for the localized delivery of therapeutic agents to both peripheral and coronary vasculature. Additionally, Advanced Catheter Therapies is developing devices to combat restenosis and catheters for endovascular debulking to clear blocked blood vessels. The company, previously known as Atlanta Catheter Therapies, Inc., rebranded in October 2011 to reflect its expanded focus on advanced catheter solutions.
Preferral
Venture Round in 2014
Preferral is a referral management system designed to streamline the referral process between primary care practices and specialists. Founded in 2013 by Jon Gautsch and headquartered in Nashville, Tennessee, the platform allows healthcare providers to manage, customize, and analyze patient referrals efficiently. By offering online referral forms that can be easily integrated into practice websites, Preferral enables patients to schedule appointments at their convenience, thereby improving access to care. This system not only reduces administrative costs for healthcare providers but also enhances communication between them. Additionally, Preferral offers valuable insights into referral relationships, aiding practices in refining their marketing efforts.
InvisionHeart
Series A in 2014
InvisionHeart is a company focused on enhancing cardiac care through innovative technology. It has developed a mobile electrocardiograph system that captures vital cardiac data, allowing a network of healthcare professionals—including physicians, nurses, and technicians—to securely access and annotate patient electrocardiogram tracings. The technology was initially created by a collaborative team of physicians and engineers at Vanderbilt University, addressing practical clinical challenges faced in heart care. With a strong leadership team and a dedicated clinical advisory board, InvisionHeart aims to improve the quality of care for heart patients, ensuring that essential cardiac information is readily available to healthcare providers regardless of their location.
Diagnovus
Seed Round in 2013
Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.
Quire, LLC is a Memphis-based company specializing in population health management through its innovative platform, Quire. This system transforms unstructured clinical notes and electronic medical records (EMRs) into structured, accessible data, allowing healthcare organizations to uncover trends and patterns within patient populations. Quire enables users to categorize, organize, and visualize patient information, facilitating the identification and treatment of high-risk individuals while also targeting healthcare spending demographics. The platform incorporates predictive analytics, automatic learning, and concept matching to enhance provider evaluation and resource allocation. By considering social and environmental factors in its analysis, Quire ensures that healthcare practices gain comprehensive insights into patient risk across their populations. Founded in 2003, Quire was previously known as Computable Genomix, LLC.
Preferral
Seed Round in 2013
Preferral is a referral management system designed to streamline the referral process between primary care practices and specialists. Founded in 2013 by Jon Gautsch and headquartered in Nashville, Tennessee, the platform allows healthcare providers to manage, customize, and analyze patient referrals efficiently. By offering online referral forms that can be easily integrated into practice websites, Preferral enables patients to schedule appointments at their convenience, thereby improving access to care. This system not only reduces administrative costs for healthcare providers but also enhances communication between them. Additionally, Preferral offers valuable insights into referral relationships, aiding practices in refining their marketing efforts.
VenX Medical
Seed Round in 2013
VenX Medical LLC is a medical device company based in Nashville, Tennessee, focused on developing innovative treatments for venous insufficiency, particularly targeting varicose veins. The company specializes in microvenous avulsion technology, offering devices such as VenX Reach and Nanophlebectomy. VenX Reach is a minimally invasive disposable device that effectively treats small to medium-sized lower limb veins, including reticular and spider veins, and can be used alongside other vein therapies like endovenous ablation and sclerotherapy. Nanophlebectomy, another of VenX Medical's offerings, is a handheld device designed to disrupt the structure of spider and reticular veins, promoting coagulation and elimination through a transdermal approach. Incorporated in 2009, VenX Medical aims to provide less invasive solutions for patients suffering from vein-related conditions.
Diagnovus
Seed Round in 2013
Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile.
Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
Diagnovus
Seed Round in 2013
Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.
Evermind
Seed Round in 2013
Evermind, Inc. is a company based in Nashville, Tennessee, founded in 2012, that specializes in monitoring home appliances to enhance the safety and well-being of individuals living alone. Its primary product, also named Evermind, sends text messages or email notifications to users when appliances are activated or deactivated. This system enables caregivers and family members to receive updates on daily activities without intruding on the individual's privacy. By tracking the usage of various electrical devices such as coffee makers, lamps, and garage door openers, Evermind provides a modern solution reminiscent of traditional community watch practices, allowing individuals to maintain their independence while ensuring that their well-being is monitored effectively.
Quire, LLC is a Memphis-based company specializing in population health management through its innovative platform, Quire. This system transforms unstructured clinical notes and electronic medical records (EMRs) into structured, accessible data, allowing healthcare organizations to uncover trends and patterns within patient populations. Quire enables users to categorize, organize, and visualize patient information, facilitating the identification and treatment of high-risk individuals while also targeting healthcare spending demographics. The platform incorporates predictive analytics, automatic learning, and concept matching to enhance provider evaluation and resource allocation. By considering social and environmental factors in its analysis, Quire ensures that healthcare practices gain comprehensive insights into patient risk across their populations. Founded in 2003, Quire was previously known as Computable Genomix, LLC.
Diagnovus
Seed Round in 2013
Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile.
Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
Pathfinder Technologies
Seed Round in 2013
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
Diagnovus
Seed Round in 2012
Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.
Pathfinder Technologies
Venture Round in 2012
Pathfinder Technologies (formerly Pathfinder Therapeutics, Inc.), a medical device company, engages in the design, development, and manufacture of solutions in the field of navigated abdominal surgery. The company provides an integrated intra-operative image guidance system for open liver surgical procedure; and accessories, including IRED localization probes, navigated RF ablators, and navigated ultrasonic aspirators. Its system consists of a software architecture that allows the surgeon to display a 3D view of the liver. Its system is used in various open liver surgery applications, including hepatic resection, open ablation, open biopsy, living donor transplant, cyst removal, and tumor removal. Pathfinder Technologies was founded in 2004 and is based in Nashville, Tennessee.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile.
Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.
Diagnovus
Seed Round in 2011
Diagnovus, established in 2011 and located in Nashville, TN, is dedicated to advancing patient health through innovative molecular diagnostics. The company focuses on developing diagnostic tests aimed at rare forms of cancer, including pediatric cancers, to enhance the decision-making process for physicians, patients, and their families. By prioritizing evidence-based solutions, Diagnovus aims to improve treatment outcomes and facilitate more effective care. Their commitment to serving the healthcare community reflects a passion for enhancing the quality of life for patients while also promoting a more efficient allocation of healthcare resources.
Goba provides sms/app/web solutions/APIs to help corporations, telecoms, tech developers, universities, and organizations of all sizes to drive more meaningful engagement with their existing audiences for a world gone mobile.
Goba LLC was founded with a passion to create technology that helps people build and maintain face-to-face relationships. Goba provides the Goba Engage ™platform for corporations, universities and technology providers that wish to incorporate greater personal engagement into their mobile strategy. Goba is headquartered in Nashville, Tennessee and also has a technology team based in Silicon Valley. Initial funding began with several local investors and early-stage Venture Capital. Popular analysts are noting how Goba is a pioneer in the personal media and SoLoMo space. Further information is available at http://www.goba.mobi.